"Olmesartan Medoxomil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to manage HYPERTENSION.
| Descriptor ID |
D000068557
|
| MeSH Number(s) |
D03.383.129.308.674 D03.383.129.617.584
|
| Concept/Terms |
Olmesartan Medoxomil- Olmesartan Medoxomil
- Medoxomil, Olmesartan
- 5-Methyl-2-oxo-1,3-dioxolen-4-yl)methoxy-4-(1-hydroxy-1-methylethyl)-2-propyl-1-(4-(2-(tetrazol-5-yl)phenyl)phenyl)methylimidazol-5-carboxylate - T287346
|
Below are MeSH descriptors whose meaning is more general than "Olmesartan Medoxomil".
Below are MeSH descriptors whose meaning is more specific than "Olmesartan Medoxomil".
This graph shows the total number of publications written about "Olmesartan Medoxomil" by people in this website by year, and whether "Olmesartan Medoxomil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Olmesartan Medoxomil" by people in Profiles.
-
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients. High Blood Press Cardiovasc Prev. 2021 May; 28(3):255-262.
-
Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):255-263.
-
Monotherapy and Dual Combination Therapies Based on Olmesartan: A Comprehensive Strategy to Improve Blood Pressure Control. High Blood Press Cardiovasc Prev. 2017 Sep; 24(3):243-253.